Clinical Trials Logo

Cesarean Section clinical trials

View clinical trials related to Cesarean Section.

Filter by:

NCT ID: NCT05950568 Completed - Cesarean Section Clinical Trials

Quadratus Lumborum Block Type III Versus Type II Versus Transversus Abdominis Plane Block in Cesarean Section

Start date: March 24, 2023
Phase: N/A
Study type: Interventional

Compare the type III and type II quadratus lumborum block (QLB) to transversus abdominis plane block (TAPB) regarding efficacy in CS

NCT ID: NCT05905861 Not yet recruiting - Postoperative Pain Clinical Trials

Scalpel Versus Diathermy for Transverse Abdominal Incision in First Elective Caesarean Section

Start date: July 2023
Phase: N/A
Study type: Interventional

The objective of this study will be to compare two methods of skin incisions during the first caesarean section (CS), that is scalpel and diathermy, assessing differences in blood loss during incision, incisional time, total surgery time, post-operative pain, wound healing, complications, and cosmetic outcomes.

NCT ID: NCT05903547 Recruiting - Cesarean Section Clinical Trials

Skin Glue Cesarean Study

Start date: August 23, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to compare cesarean incision outcomes between patients with incision closed with the Dermabond Prineo system compared to standard subcuticular suture.

NCT ID: NCT05900492 Active, not recruiting - Cesarean Section Clinical Trials

Incidence of Uterine Cesarean Scar Niche After Cesarean Delivery

Start date: January 1, 2023
Phase:
Study type: Observational

To assess the incidence of cesarean scar niche and its risk factors in a prospectively collected population.

NCT ID: NCT05892913 Completed - Pregnancy Clinical Trials

The Effect of Low-dose Atropine on Sympathetic Blockade in Spinal Cesarean Section Patients

Start date: July 19, 2023
Phase: Phase 4
Study type: Interventional

The most common side effect in cesarean section surgeries performed under spinal anesthesia is hypotension, which is seen in over 80% and can cause significant morbidity for the mother and fetus. This side effect results from the sympathetic blocking effect, which also causes bradycardia. A combined approach is supported in the prevention and treatment of hypotension, which recommends adequate fluid support, low-dose spinal anesthesia, and appropriate vasopressor (such as ephedrine, and phenylephrine) and, if bradycardia develops, the use of atropine as a parasympatholytic agent. In this study, the investigators planned to investigate the possible benefits of preemptive administration of atropine, the dose of which is calculated in proportion to the patient's weight, as soon as a 10% decrease in heart rate is detected, in order to balance the sympathetic blockade due to spinal anesthesia in cesarean section operations.

NCT ID: NCT05879536 Recruiting - Post Operative Pain Clinical Trials

The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section.

TRON
Start date: May 23, 2023
Phase:
Study type: Observational

It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.

NCT ID: NCT05857059 Recruiting - Obesity Clinical Trials

Misoprostol for Induction of Labor in Obese Women: Comparison Between 25 and 50 mcg Oral Administration

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

In recent decades, obesity has become a prevalent issue in Portugal, with 38.6% and 13.8% of the population being overweight or obese, respectively. Obese pregnant women have a higher rate of obstetric complications, including hypertensive complications, gestational diabetes and fetal macrosomia, leading to increased induction of labor (IOL) and cesarean section (CS) rates. To determine the effect of increasing oral misoprostol dose on CS rate in obese pregnant women undergoing IOL, a randomized controlled trial with a sample size of 114 cases in each group was calculated to detect a 15% difference in CS rate. The primary objective is to determine the effect of increasing oral misoprostol dose, with secondary goals being to compare successful IOL rates and their relationship with oral misoprostol dose, as well as to evaluate tolerability and side effects in relation to different doses of oral misoprostol.

NCT ID: NCT05846100 Recruiting - Cesarean Section Clinical Trials

Conventional Palpation Versus Ultrasound Assisted Spinal Anesthesia in Obstetrics

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Spinal anesthesia in obese parturients is commonly difficult yet there are no guidelines to direct best practice. The failure leads to suboptimal patient outcomes. Ultrasonography is now considered standard care for central venous access and regional anesthesia and it can be used to visualize the anatomy of the spine for this procedure. Goal of the study Evaluate the benefits of preprocedural ultrasound scanning to facilitate neuraxial anesthesia and improve the first-attempt success rate in obese parturients.

NCT ID: NCT05840406 Not yet recruiting - Postoperative Pain Clinical Trials

Effect of a Transversus Abdominis Plane Block on Wound Healing, Stress, and Immune Response After a Cesarean Delivery

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The primary purpose of this study is to determine whether the addition of a TAP block to standard analgesia after the cesarean delivery will impact postoperative wound healing and attenuate postoperative stress and immune response. Random allocation of participants in 3 groups: group SA (standard analgesia), group L (TAP block with levobupivacaine), and group D (TAP block with levobupivacaine + dexmedetomidine). All participants will undergo elective cesarean section through Pfannestiel incision under spinal anesthesia. They will receive standard postoperative pain management with acetaminophen, nonsteroidal anti-inflammatory drugs, and tramadol. Groups L and D will additionally receive bilateral ultrasound-guided TAP block with 20 ml 0,25% levobupivacaine or with 20 ml 0,25% levobupivacaine with the addition of 0,5 μg/kg dexmedetomidine. TAP block will be performed in the theatre immediately after the cesarean delivery. Venous blood samples will be collected before the surgery and on the third postoperative day. Complete blood count and serum cortisol levels will be measured. REEDA scale will be used for assessing wound healing.

NCT ID: NCT05790954 Completed - Cesarean Section Clinical Trials

The Effect of Pre-Cesarean Section Guided Imagery

Start date: March 27, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of guided imagery applied before cesarean section on preoperative anxiety, fear and physiological parameters. The study will be carried out in two different groups. The practice will start with meeting the women 3 days before cesarean section. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out random. The following applications will be made to the groups.